These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 22491770)

  • 81. Host defence and persistent human papillomavirus infection.
    Stanley M
    Curr Opin Virol; 2021 Dec; 51():106-110. PubMed ID: 34628358
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Protamine Sulfate Is a Potent Inhibitor of Human Papillomavirus Infection
    Young JM; Zine El Abidine A; Gómez-Martinez RA; Bondu V; Sterk RT; Surviladze Z; Ozbun MA
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0151321. PubMed ID: 34723633
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Innate immune response against HPV: Possible crosstalking with endocervical γδ T cells.
    Dogan S; Terzioglu E; Ucar S
    J Reprod Immunol; 2021 Nov; 148():103435. PubMed ID: 34741834
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Activities of stromal and immune cells in HPV-related cancers.
    Barros MR; de Melo CML; Barros MLCMGR; de Cássia Pereira de Lima R; de Freitas AC; Venuti A
    J Exp Clin Cancer Res; 2018 Jul; 37(1):137. PubMed ID: 29976244
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Episome partitioning and symmetric cell divisions: Quantifying the role of random events in the persistence of HPV infections.
    Beneteau T; Selinger C; Sofonea MT; Alizon S
    PLoS Comput Biol; 2021 Sep; 17(9):e1009352. PubMed ID: 34491986
    [TBL] [Abstract][Full Text] [Related]  

  • 86. New Insights in the Pathogenesis of HPV Infection and the Associated Carcinogenic Processes: The Role of Chronic Inflammation and Oxidative Stress.
    Georgescu SR; Mitran CI; Mitran MI; Caruntu C; Sarbu MI; Matei C; Nicolae I; Tocut SM; Popa MI; Tampa M
    J Immunol Res; 2018; 2018():5315816. PubMed ID: 30225270
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.
    Woodby B; Scott M; Bodily J
    Prog Mol Biol Transl Sci; 2016; 144():169-238. PubMed ID: 27865458
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Latent papillomavirus infections and their regulation.
    Doorbar J
    Curr Opin Virol; 2013 Aug; 3(4):416-21. PubMed ID: 23816390
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The immune response to papillomavirus during infection persistence and regression.
    Hibma MH
    Open Virol J; 2012; 6():241-8. PubMed ID: 23341859
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Immunological and structural remodeling in human papillomavirus-induced warts and Bowen disease.
    Iwatsuki K; Nakayama Y; Hamada T; Nakanishi G; Shirafuji Y; Morizane S
    Eur J Dermatol; 2013 Apr; ():. PubMed ID: 23644544
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The role of furin in papillomavirus infection.
    Day PM; Schiller JT
    Future Microbiol; 2009 Dec; 4(10):1255-62. PubMed ID: 19995186
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The cytoskeleton in papillomavirus infection.
    Bienkowska-Haba M; Sapp M
    Viruses; 2011 Mar; 3(3):260-271. PubMed ID: 21994730
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The ecology of human papillomavirus-induced epithelial lesions and the role of somatic evolution in their progression.
    Orlando PA; Brown JS; Gatenby RA; Guliano AR
    J Infect Dis; 2013 Aug; 208(3):394-402. PubMed ID: 23599315
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system.
    Grabowska AK; Riemer AB
    Open Virol J; 2012; 6():249-56. PubMed ID: 23341860
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Immunosuppression facilitates the reactivation of latent papillomavirus infections.
    Maglennon GA; McIntosh PB; Doorbar J
    J Virol; 2014 Jan; 88(1):710-6. PubMed ID: 24173230
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The biology of papillomavirus latency.
    Maglennon GA; Doorbar J
    Open Virol J; 2012; 6():190-7. PubMed ID: 23341854
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Host responses to infection with human papillomavirus.
    Stanley MA; Sterling JC
    Curr Probl Dermatol; 2014; 45():58-74. PubMed ID: 24643178
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Prevalence of human papillomavirus (HPV) in upper respiratory tract mucosa in a group of pre-school children.
    Szydłowski J; Jonczyk-Potoczna K; Pucher B; Buraczyńska-Andrzejewska B; Prauzińska M; Kolasińska-Lipińska J; Krauss H; Piątek J; Żukiewicz-Sobczak W
    Ann Agric Environ Med; 2014; 21(4):822-4. PubMed ID: 25528927
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Genital warts: a comprehensive review.
    Yanofsky VR; Patel RV; Goldenberg G
    J Clin Aesthet Dermatol; 2012 Jun; 5(6):25-36. PubMed ID: 22768354
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.
    Sasagawa T; Takagi H; Makinoda S
    J Infect Chemother; 2012 Dec; 18(6):807-15. PubMed ID: 23117294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.